Table 2 Pain and clinical function outcome postoperation
Variable | TKA (N = 471) | THA (N = 523) |
|---|---|---|
POD1 | ||
VAS-night | 3.14 ± 1.41 | 2.79 ± 1.71 |
VAS-ambulation | 4.99 ± 1.73 | 4.11 ± 1.88 |
ROM° | 98.11 ± 11.29 | 97.69 ± 7.47 |
HHS (points) | – | 58.38 ± 13.51 |
KSS (points) | 54.03 ± 13.09 | – |
POD3 | ||
VAS-night | 2.67 ± 1.29 | 2.26 ± 1.35 |
VAS-ambulation | 3.93 ± 1.54 | 2.67 ± 1.66 |
ROM° | 110.20 ± 5.96 | 110.13 ± 6.07 |
HHS (points) | – | 67.00 ± 11.25 |
KSS (points) | 61.49 ± 11.52 | – |
POD14 | ||
VAS-night | 1.52 ± 0.93 | 1.60 ± 1.06 |
VAS-ambulation | 2.18 ± 1.11 | 2.23 ± 1.22 |
ROM° | 112.34 ± 4.63 | 113.08 ± 4.83 |
HHS (points) | – | 76.65 ± 8.56 |
KSS (points) | 77.32 ± 7.46 | – |
POM3 | ||
VAS-night | 0.98 ± 0.81 | 1.04 ± 0.83 |
VAS-ambulation | 1.48 ± 1.13 | 1.54 ± 1.10 |
ROM° | 110.85 ± 6.65 | 112.14 ± 6.73 |
HHS (points) | – | 83.23 ± 4.64 |
KSS (points) | 81.65 ± 4.51 | – |
Oxycodone | ||
Number of patients requiring | 68 | 31 |
Dose (morphine eq.) | 7.71 ± 15.39 | 3.71 ± 9.02 |
Parecoxib | ||
Number of patients requiring | 52 | 27 |
Dose | 5.90 ± 14.64 | 3.54 ± 11.63 |